ANATARA LIFESCIENCES LTD - Announcements

0.00%

0.8¢

Market Cap $1.708M

Healthcare Biotechnology

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is... Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.More

Announcements

Filter Results

All Price Sensitive Only

ANR	Clinical Trials Update	PRICE SENSITIVE	16/12/21	172.33KB	Share
ANR	Change of Director's Interest Notice		13/12/21	614.06KB	Share
ANR	Notification regarding unquoted securities - ANR		13/12/21	28.03KB	Share
ANR	Notification regarding unquoted securities - ANR		13/12/21	28.04KB	Share
ANR	Notification regarding unquoted securities - ANR		13/12/21	28.62KB	Share
ANR	Application for quotation of securities - ANR		10/12/21	24.96KB	Share
ANR	Anatara Strengthens the Team with New Appointments		06/12/21	168.7KB	Share
ANR	Results of Meeting		16/11/21	281.5KB	Share
ANR	AGM CEO Presentation	PRICE SENSITIVE	16/11/21	1.05MB	Share
ANR	Chairman's Address to Shareholders	PRICE SENSITIVE	16/11/21	244.05KB	Share
ANR	Appendix 2A		04/11/21	536.86KB	Share
ANR	Appendix 4C & Q1 FY22 Activities Report	PRICE SENSITIVE	29/10/21	350.69KB	Share
ANR	Notification regarding unquoted securities - ANR		27/10/21	25.03KB	Share
ANR	Notification of cessation of securities - ANR		21/10/21	21.77KB	Share
ANR	Notification of cessation of securities - ANR		21/10/21	21.77KB	Share
ANR	Appendix 4G and Corporate Governance Statement		19/10/21	384.37KB	Share
ANR	Annual Report to shareholders		15/10/21	1.64MB	Share
ANR	Notice of Annual General Meeting/Proxy Form		15/10/21	989.43KB	Share
ANR	Annual General Meeting & Director Nominations		29/09/21	227.52KB	Share
ANR	Change of Director's Interest Notice		13/09/21	213.02KB	Share
ANR	Notification regarding unquoted securities - ANR		09/09/21	28.01KB	Share
ANR	Meet the CEO Investor Webinar		07/09/21	177.7KB	Share
ANR	Investor Presentation	PRICE SENSITIVE	06/09/21	1.78MB	Share
ANR	Application for quotation of securities - ANR		26/08/21	25.52KB	Share
ANR	Appendix 4E & Financial Report 30 June 2021	PRICE SENSITIVE	24/08/21	977.89KB	Share
ANR	Anatara launches IBS-D Clinical Trial recruitment website		20/08/21	211.88KB	Share
ANR	Notification regarding unquoted securities - ANR		17/08/21	25.46KB	Share
ANR	Application for quotation of securities - ANR		17/08/21	25.42KB	Share
ANR	Successful Piglet Study	PRICE SENSITIVE	06/08/21	204.94KB	Share
ANR	Monthly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/21	399.65KB	Share
ANR	Anatara Chair Transition		26/07/21	801.29KB	Share
ANR	Anatara progressing towards first human clinical studies		31/05/21	225.35KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/21	499.7KB	Share
ANR	Change in substantial holding		21/04/21	731.06KB	Share
ANR	Ethics approve Adult Psychological Functioning Trial start		20/04/21	228.52KB	Share
ANR	Anatara announces Australian patent grant for Detach	PRICE SENSITIVE	16/04/21	257.69KB	Share
ANR	Change in substantial holding		13/04/21	78.61KB	Share
ANR	Market Update	PRICE SENSITIVE	07/04/21	257.25KB	Share
ANR	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/21	620.85KB	Share
ANR	Completion of Unmarketable Parcel Share Buy-Back		10/02/21	219.86KB	Share
ANR	Anatara Receives Ethics Approval to Start IBS Trial		08/02/21	196.19KB	Share
ANR	Expired Options		03/02/21	118.3KB	Share
ANR	R&D Tax Incentive Received		03/02/21	193.99KB	Share
ANR	Anatara Successful Poultry Trial		01/02/21	164.95KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/21	381.22KB	Share
ANR	Unmarketable Parcel Share Buy-back Reminder		22/01/21	176.02KB	Share
ANR	Buy-back of Unmarketable Parcels of Shares		14/12/20	447.71KB	Share
ANR	Anatara Human Health Update		08/12/20	171.44KB	Share
ANR	Change of Director's Interest Notice		04/12/20	602.88KB	Share
ANR	Cleansing Notice		04/12/20	162.84KB	Share
ANR	Appendix 3G		04/12/20	284.12KB	Share
ANR	Appendix 3G		04/12/20	289.5KB	Share
ANR	Appendix 2A		04/12/20	195.27KB	Share
ANR	Final Director's Interest Notice		30/11/20	141.23KB	Share
ANR	Amended Constitution		27/11/20	518.69KB	Share
ANR	Results of Meeting		26/11/20	226.9KB	Share
ANR	AGM Presentation		26/11/20	1.3MB	Share
ANR	Chairman's Address to Shareholders		26/11/20	154.42KB	Share
ANR	Change of Director's Interest Notice		19/11/20	577.93KB	Share
ANR	Appendix 2A		18/11/20	206.73KB	Share
ANR	Anatara Animal Health Update		18/11/20	187.16KB	Share
ANR	$1.4m raised through the completed SPP	PRICE SENSITIVE	16/11/20	165.21KB	Share
ANR	Change in substantial holding - Tiga Trading Pty Ltd		30/10/20	146.47KB	Share
ANR	Change in substantial holding from TEK		30/10/20	136.09KB	Share
ANR	Investor Presentation		29/10/20	1.58MB	Share
ANR	Placement and Performance Rights Cleansing Notice		28/10/20	158.38KB	Share
ANR	Appendix 2A		28/10/20	255.89KB	Share
ANR	SPP Offer Booklet	PRICE SENSITIVE	28/10/20	385.11KB	Share
ANR	SPP Cleansing Notice		28/10/20	158.34KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/20	418.66KB	Share
ANR	Notice of Annual General Meeting/Proxy Form		27/10/20	934.77KB	Share
ANR	Appendix 4G and Corporate Governance Statement		27/10/20	513.94KB	Share
ANR	Annual Report to shareholders		27/10/20	1.88MB	Share
ANR	Proposed issue of Securities - ANR		21/10/20	26.93KB	Share
ANR	Proposed issue of Securities - ANR		21/10/20	27.62KB	Share
ANR	Proposed issue of Securities - ANR		21/10/20	25.23KB	Share
ANR	Completed Placement and announced Share Purchase Plan	PRICE SENSITIVE	21/10/20	255.66KB	Share
ANR	Trading Halt	PRICE SENSITIVE	19/10/20	141.23KB	Share
ANR	Non-Executive Director Retirement		19/10/20	170.4KB	Share
ANR	Appendix 2A		15/09/20	280.13KB	Share
ANR	Investor Presentation		08/09/20	1.03MB	Share
ANR	Appendix 3G		03/09/20	301.85KB	Share
ANR	Appendix 4E & Financial Report 30 June 2020	PRICE SENSITIVE	24/08/20	1.18MB	Share
ANR	Appendix 3G		11/08/20	327.29KB	Share
ANR	Anatara Animal Health Update		10/08/20	197.16KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/20	566.49KB	Share
ANR	Cancelled Options		03/07/20	117.58KB	Share
ANR	Partnering Update	PRICE SENSITIVE	23/06/20	236.49KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/20	485.13KB	Share
ANR	Anatara Market Update COVID-19		07/04/20	188.97KB	Share
ANR	Registered Office Change		23/03/20	83.01KB	Share
ANR	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/20	400.43KB	Share
ANR	Anatara Preclinical Program Summary	PRICE SENSITIVE	22/01/20	381.28KB	Share
ANR	Change in substantial holding		20/01/20	1.42MB	Share
ANR	Appendix 3B		16/01/20	229.57KB	Share
ANR	Appendix 4C - quarterly	PRICE SENSITIVE	15/01/20	434.82KB	Share
ANR	Anatara finalises draft protocol for IBS Clinical Trial		20/12/19	255.85KB	Share
ANR	Anatara achieves preclinical milestone	PRICE SENSITIVE	19/12/19	275.45KB	Share
ANR	Appendix 3B		11/12/19	229.12KB	Share
ANR	Anatara Investor Presentation and Update		28/11/19	2.52MB	Share

ANR Clinical Trials Update
16/12/21	PRICE SENSITIVE	172.33KB	Share
ANR Change of Director's Interest Notice
13/12/21		614.06KB	Share
ANR Notification regarding unquoted securities - ANR
13/12/21		28.03KB	Share
ANR Notification regarding unquoted securities - ANR
13/12/21		28.04KB	Share
ANR Notification regarding unquoted securities - ANR
13/12/21		28.62KB	Share
ANR Application for quotation of securities - ANR
10/12/21		24.96KB	Share
ANR Anatara Strengthens the Team with New Appointments
06/12/21		168.7KB	Share
ANR Results of Meeting
16/11/21		281.5KB	Share
ANR AGM CEO Presentation
16/11/21	PRICE SENSITIVE	1.05MB	Share
ANR Chairman's Address to Shareholders
16/11/21	PRICE SENSITIVE	244.05KB	Share
ANR Appendix 2A
04/11/21		536.86KB	Share
ANR Appendix 4C & Q1 FY22 Activities Report
29/10/21	PRICE SENSITIVE	350.69KB	Share
ANR Notification regarding unquoted securities - ANR
27/10/21		25.03KB	Share
ANR Notification of cessation of securities - ANR
21/10/21		21.77KB	Share
ANR Notification of cessation of securities - ANR
21/10/21		21.77KB	Share
ANR Appendix 4G and Corporate Governance Statement
19/10/21		384.37KB	Share
ANR Annual Report to shareholders
15/10/21		1.64MB	Share
ANR Notice of Annual General Meeting/Proxy Form
15/10/21		989.43KB	Share
ANR Annual General Meeting & Director Nominations
29/09/21		227.52KB	Share
ANR Change of Director's Interest Notice
13/09/21		213.02KB	Share
ANR Notification regarding unquoted securities - ANR
09/09/21		28.01KB	Share
ANR Meet the CEO Investor Webinar
07/09/21		177.7KB	Share
ANR Investor Presentation
06/09/21	PRICE SENSITIVE	1.78MB	Share
ANR Application for quotation of securities - ANR
26/08/21		25.52KB	Share
ANR Appendix 4E & Financial Report 30 June 2021
24/08/21	PRICE SENSITIVE	977.89KB	Share
ANR Anatara launches IBS-D Clinical Trial recruitment website
20/08/21		211.88KB	Share
ANR Notification regarding unquoted securities - ANR
17/08/21		25.46KB	Share
ANR Application for quotation of securities - ANR
17/08/21		25.42KB	Share
ANR Successful Piglet Study
06/08/21	PRICE SENSITIVE	204.94KB	Share
ANR Monthly Activities/Appendix 4C Cash Flow Report
28/07/21	PRICE SENSITIVE	399.65KB	Share
ANR Anatara Chair Transition
26/07/21		801.29KB	Share
ANR Anatara progressing towards first human clinical studies
31/05/21		225.35KB	Share
ANR Appendix 4C - quarterly
27/04/21	PRICE SENSITIVE	499.7KB	Share
ANR Change in substantial holding
21/04/21		731.06KB	Share
ANR Ethics approve Adult Psychological Functioning Trial start
20/04/21		228.52KB	Share
ANR Anatara announces Australian patent grant for Detach
16/04/21	PRICE SENSITIVE	257.69KB	Share
ANR Change in substantial holding
13/04/21		78.61KB	Share
ANR Market Update
07/04/21	PRICE SENSITIVE	257.25KB	Share
ANR Half Yearly Report and Accounts
23/02/21	PRICE SENSITIVE	620.85KB	Share
ANR Completion of Unmarketable Parcel Share Buy-Back
10/02/21		219.86KB	Share
ANR Anatara Receives Ethics Approval to Start IBS Trial
08/02/21		196.19KB	Share
ANR Expired Options
03/02/21		118.3KB	Share
ANR R&D Tax Incentive Received
03/02/21		193.99KB	Share
ANR Anatara Successful Poultry Trial
01/02/21		164.95KB	Share
ANR Appendix 4C - quarterly
28/01/21	PRICE SENSITIVE	381.22KB	Share
ANR Unmarketable Parcel Share Buy-back Reminder
22/01/21		176.02KB	Share
ANR Buy-back of Unmarketable Parcels of Shares
14/12/20		447.71KB	Share
ANR Anatara Human Health Update
08/12/20		171.44KB	Share
ANR Change of Director's Interest Notice
04/12/20		602.88KB	Share
ANR Cleansing Notice
04/12/20		162.84KB	Share
ANR Appendix 3G
04/12/20		284.12KB	Share
ANR Appendix 3G
04/12/20		289.5KB	Share
ANR Appendix 2A
04/12/20		195.27KB	Share
ANR Final Director's Interest Notice
30/11/20		141.23KB	Share
ANR Amended Constitution
27/11/20		518.69KB	Share
ANR Results of Meeting
26/11/20		226.9KB	Share
ANR AGM Presentation
26/11/20		1.3MB	Share
ANR Chairman's Address to Shareholders
26/11/20		154.42KB	Share
ANR Change of Director's Interest Notice
19/11/20		577.93KB	Share
ANR Appendix 2A
18/11/20		206.73KB	Share
ANR Anatara Animal Health Update
18/11/20		187.16KB	Share
ANR $1.4m raised through the completed SPP
16/11/20	PRICE SENSITIVE	165.21KB	Share
ANR Change in substantial holding - Tiga Trading Pty Ltd
30/10/20		146.47KB	Share
ANR Change in substantial holding from TEK
30/10/20		136.09KB	Share
ANR Investor Presentation
29/10/20		1.58MB	Share
ANR Placement and Performance Rights Cleansing Notice
28/10/20		158.38KB	Share
ANR Appendix 2A
28/10/20		255.89KB	Share
ANR SPP Offer Booklet
28/10/20	PRICE SENSITIVE	385.11KB	Share
ANR SPP Cleansing Notice
28/10/20		158.34KB	Share
ANR Appendix 4C - quarterly
28/10/20	PRICE SENSITIVE	418.66KB	Share
ANR Notice of Annual General Meeting/Proxy Form
27/10/20		934.77KB	Share
ANR Appendix 4G and Corporate Governance Statement
27/10/20		513.94KB	Share
ANR Annual Report to shareholders
27/10/20		1.88MB	Share
ANR Proposed issue of Securities - ANR
21/10/20		26.93KB	Share
ANR Proposed issue of Securities - ANR
21/10/20		27.62KB	Share
ANR Proposed issue of Securities - ANR
21/10/20		25.23KB	Share
ANR Completed Placement and announced Share Purchase Plan
21/10/20	PRICE SENSITIVE	255.66KB	Share
ANR Trading Halt
19/10/20	PRICE SENSITIVE	141.23KB	Share
ANR Non-Executive Director Retirement
19/10/20		170.4KB	Share
ANR Appendix 2A
15/09/20		280.13KB	Share
ANR Investor Presentation
08/09/20		1.03MB	Share
ANR Appendix 3G
03/09/20		301.85KB	Share
ANR Appendix 4E & Financial Report 30 June 2020
24/08/20	PRICE SENSITIVE	1.18MB	Share
ANR Appendix 3G
11/08/20		327.29KB	Share
ANR Anatara Animal Health Update
10/08/20		197.16KB	Share
ANR Appendix 4C - quarterly
29/07/20	PRICE SENSITIVE	566.49KB	Share
ANR Cancelled Options
03/07/20		117.58KB	Share
ANR Partnering Update
23/06/20	PRICE SENSITIVE	236.49KB	Share
ANR Appendix 4C - quarterly
27/04/20	PRICE SENSITIVE	485.13KB	Share
ANR Anatara Market Update COVID-19
07/04/20		188.97KB	Share
ANR Registered Office Change
23/03/20		83.01KB	Share
ANR Half Yearly Report and Accounts
25/02/20	PRICE SENSITIVE	400.43KB	Share
ANR Anatara Preclinical Program Summary
22/01/20	PRICE SENSITIVE	381.28KB	Share
ANR Change in substantial holding
20/01/20		1.42MB	Share
ANR Appendix 3B
16/01/20		229.57KB	Share
ANR Appendix 4C - quarterly
15/01/20	PRICE SENSITIVE	434.82KB	Share
ANR Anatara finalises draft protocol for IBS Clinical Trial
20/12/19		255.85KB	Share
ANR Anatara achieves preclinical milestone
19/12/19	PRICE SENSITIVE	275.45KB	Share
ANR Appendix 3B
11/12/19		229.12KB	Share
ANR Anatara Investor Presentation and Update
28/11/19		2.52MB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $1.708M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$1.84K	230.0K

Buyers (Bids)

No.	Vol.	Price($)
1	8893	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	908675	3

View Market Depth

No.	Vol.	Price($)
1	8893	0.008
6	1101919	0.007
9	2276169	0.006
10	3812000	0.005
6	3500052	0.004

Price($)	Vol.	No.
0.009	908675	3
0.010	1502600	4
0.011	520150	2
0.012	755000	2
0.013	300000	1

Last trade - 15.55pm 04/09/2025 (20 minute delay)

ANR (ASX) Chart

ANATARA LIFESCIENCES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories